Stockholders' Equity

3 Months Ended

Mar. 31, 2017

Stockholders' Equity [Abstract]

Stockholders Equity Note Disclosure [Text Block]

10. Stockholders’ Equity

Preferred Stock

There were no issuances of preferred stock during the three month periods ended March 31, 2017 and 2016.

Common Stock

The Company is authorized to issue 110,000,000 shares of common stock, $.001 par value per share. As of March 31, 2017, there were 82,844,322 shares of common stock outstanding.

The Company issued 84,188 and 209,438 shares of common stock, respectively, as a result of the vesting of Restricted Stock Awards (RSA) during the three month period ended March 31, 2017 and 2016. See Note 11 for additional information regarding RSA activity. There was no vesting of RSAs during the three month period ended March 31, 2016.

Shares of common stock issued as a result of Non-Qualified Stock Option (NQSO) exercises and realized gross proceeds during the three month period ended March 31, 2017 were 30,000 and $17,100, respectively, from the exercise of such non-qualified stock options. No tax benefit has been associated with the exercise of stock options for the three month period ended March 31, 2017, because of the existence of net operating loss carryforwards for which there is a full valuation allowance. There were no stock options exercised during three month period ended March 31, 2016. See Note 11 for additional information regarding the stock incentive plans.